Rosy  Wills

Rosy Wills

Followers 0
Following 0
According to the market research report ECMO machine market for the forecast period of 2016 to 2021.This market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654A number of factors such as the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to heart & lung transplantation, growing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements are the significant factors driving the growth of this market.In addition, the growing aging population and the number of people suffering from cardiopulmonary diseases in populous countries such as India and China are factors that are expected to offer significant growth opportunities for ECMO systems.On the basis of region, the ECMO machine market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and the Rest of the World.The Asia-Pacific market is projected to grow at the highest CAGR and serve as a revenue pocket for companies offering ECMO systems.Based on the modality, the ECMO machine market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV).
According to the research report the global ambulatory EHR market size is projected to reach USD 6.8 billion by 2025 from USD 5.2 billion in 2020, at a CAGR of 5.7% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235617627Growth in the global ambulatory EHR market can primarily be attributed to various factors such as government support for the adoption of EHR solutions, increasing number of outpatient care centers, growing patient volume due to the global outbreak of COVID-19, and the need to curtail healthcare costs.On the other hand, market growth is limited to a certain extent due to factors such as reluctance to adopt EHR solutions in developing countries, heavy infrastructure investments, and the high cost of deployment.In 2019, North America accounted for the largest share of the market.The ambulatory EHR market is predominantly divided into five major geographies, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.North America accounted for the largest share of this market, followed by North America.Growth in the North American market can be attributed to factors such as federal mandates, the increasing geriatric population, collaboration between stakeholders, the need to curtail healthcare costs, payment deductions driving the adoption of EHR, conferences and workshops to raise awareness in the US, growing efforts to enhance healthcare delivery, and the adoption of digital recordkeeping in Canada.The cloud-based solutions segment is projected to occupy the majority of the market share during the forecast period.Based on delivery mode, the hospital EHR market is segmented into on-premise and cloud-based solutions.In 2019, the cloud-based solutions segment accounted for the largest share of the market.The market is mainly driven by the advantages associated with cloud-based solutions, which include flexibility and cost reductions in healthcare delivery.Practice management application is the largest application segment in the marketOn the basis of application, the global market has been segmented into practice management, patient management, e-prescribing, referral management, population health management, decision support, and health analytics.
According to research report the cardiac monitoring devices market is expected to reach $30.56 billion by 2027 from $22.12 billion in 2019, at a CAGR of 4.0%.Factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices are expected to propel the growth of the market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55Objectives of the Study• To define, describe, and forecast the cardiac monitoring market by product, end user, and region• To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)• To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market• To analyze market opportunities for stakeholders and to provide details of the competitive landscape for market leaders• To forecast the size of the cardiac monitoring market in North America, Europe, Asia, and the Rest of the World• To profile key players and comprehensively analyze their core competencies• To track and analyze competitive developments such as product launches, agreements, partnerships, and other developments in the cardiac monitoring and cardiac rhythm management devices marketAsia is expected to grow at the highest CAGR during the forecast periodOn the basis of region, the CM & CRM devices market is segmented into North America, Europe, Asia, and RoW.Asia is expected to grow at the highest CAGR during the forecast period.Factors such as growth in the geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies, and less stringent regulations are fuelling the demand for CM & CRM devices in this region.Based on end user, the cardiac monitoring devices market is segmented into hospitals, home and ambulatory care settings, and other end users.In 2017, the hospitals segment accounted for the largest share of the market.The large share of this segment can primarily be attributed to the increasing use of these devices in hospitals, increasing burden of cardiovascular & coronary heart diseases, increasing number of patient visits to physician offices for the principal diagnosis of CVD & CHD, and growing number of cardiac implant procedures.Based on product, the cardiac rhythm management devices market is segmented into defibrillators and pacemakers.
According to the new market research report Defibrillators Market is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017 at a CAGR of 3.1%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549Factors such as technological advancements in defibrillators, rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market.However, issues related to the use of implantable and automated external defibrillators are expected to restrain the growth of the defibrillators market in the forecast period.The ICDs segment is expected to account for the largest share of the global market in 2017.Factors such as the development of technologically advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and S-ICD systems across the globe are contributing to the large share of this segment.ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds).The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs).Know How this Report Will Help You!> What are the Known and Unknown Adjacencies Impacting the Defibrillators Market?> What will your New Revenue Sources be?> Who will be your Top Customer; what will make them switch?> Defend your Market Share or Win Competitors> Get a Scorecard for Target PartnersOn the basis of products, the external defibrillator market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators.The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs).The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds).
According to research report the global eHealth Market is projected to reach USD 132.35 Billion by 2023 from USD 47.60 Billion in 2018, at a CAGR of 22.7%.The market is fragmented and highly-competitive in nature, which consists of several large to medium-sized companies that compete with each other for increasing their foothold in different segments of the market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=11513143Cerner (US) held the leading position in the eHealth market with the largest market share in 2017.The company has a robust eHealth product portfolio, including EMR/EHR solutions, PACs, hospital information systems, and others.With its wide presence, Cerner remains the largest provider of a comprehensive range of EHR solutions to hospitals and ambulatory care centers.The company significantly focuses on enhancing its existing portfolio and broadly invests in R activities to develop innovative products and attain a competitive advantage in the market.In particular, the company invested USD 187.0 million in R in 2016, an increase of 2% from 2015.
According to research report Autotransfusion Market is projected to reach USD 505 million by 2024 from USD 395 million in 2019 at a CAGR of 5.0%.Autotransfusion products, by type, accounted for the largest share of the autotransfusion systems market, in 2019.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141903480The growth of the autotransfusion devices market is driven by the increasing number of surgical procedures, rising number of transplant procedures, advantages of autotransfusion, and scarcity of donated blood/allogenic blood.North America, by region, held the largest share of the autotransfusion market in 2019.The large share of the North American market can mainly be attributed to the high and growing prevalence of target health conditions (cardiovascular, orthopedic, and trauma cases), increasing number of major transplant procedures, scarcity of allogenic blood, preference for autologous blood (due to its advantages), and the strong presence of key market players in the region.Autotransfusion products, by type, accounted for the largest share of the autotransfusion systems market, in 2019.On the basis of type, the autotransfusion devices market is segmented into autotransfusion products & accessories.The autotransfusion products segment accounted for the largest share of the autotransfusion systems market in 2019.Autotransfusion products are associated with a number of advantages, which are expected to boost its adoption in the coming years.These components prevent the transmission of transfusion-related blood-borne diseases in patients, and they also provide more compatible blood in comparison to autologous blood transfusions.These advantages are likely to increase the demand for autotransfusion products during the forecast period.The cardiac surgeries segment, by application, is expected to register the highest growth rate in the autotransfusion devices market during the forecast period in 2019.On the basis of application, the autotransfusion market is segmented into Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures.The cardiac surgeries segment is expected to register the highest growth rate due to the high prevalence of cardiac diseases and recommendations for autologous transfusion (by entities such as the WHO) during cardiac surgeries.Becton, Dickinson and Company (US), Zimmer Biomet Holdings, Inc. (US), Teleflex Incorporated (US), and Haemonetics Corporation (US) are some of the major players operating in the North American autotransfusion market.Request Free Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=141903480
According to research report Artificial Tendons Market is expected to reach USD 35.0 million by 2023 from USD 18.5 million in 2018, at a CAGR of 13.6% during the forecast period (2018-2023).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=176955103The key factors driving the growth of this artificial tendons market include increasing incidence of sports injuries, growing number of initiatives to increase the awareness about artificial tendons and ligaments, increasing research activities on artificial tendons and ligaments, increasing preference for minimally invasive surgeries, benefits of artificial tendons and ligaments, and the issues related to the use of orthobiologics.Europe to hold the largest share of the artificial tendons market in 2018In 2018, Europe is projected to account for the largest share of the artificial tendons and ligaments market, followed by Asia Pacific.The market for artificial tendons and ligaments in this region is driven by the increasing number of government initiatives to encourage sports; increasing number conferences, meetings, symposia, and workshops to showcase the latest sports technologies in the UK; increasing cases of sports-related injuries; rising cases of knee replacements; minimal out-of-pocket expenditure for medical devices; increasing number of agreements between organizations, universities, and companies in Germany; increasing aging population; and growing initiatives to increase awareness about artificial tendons and ligaments in France.Knee injuries to account for the largest share of the artificial tendons market in 2018The artificial tendons and ligaments market is segmented on the basis of application into knee injuries, shoulder injuries, foot and ankle injuries, and other injuries (spine and hip injuries).In 2018, the knee injuries segment is expected to register the largest share of the global artificial tendons market and is estimated to grow at the highest CAGR during the forecast period.This can be attributed to the increasing public participation in sports and athletic activities, increasing awareness, and the benefits of artificial tendons and ligaments.The key players in the global artificial tendons and ligaments market are LARS (France), Neoligaments (UK), Cousin Biotech (France), Orthomed S.A.S.(France), FX Solutions (France), Shanghai PINE Biotech (China), and Mathys AG Bettlach (Switzerland).Request Free Report Sample: https://www.marketsandmarkets.com/requestsample.asp?id=176955103
According to research report the Neuroscience Antibodies Market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=129888612Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.On the other hand, quality and cost concerns over the production of antibodies are the major factor restraining the growth of this market.In 2018, North America is expected to dominate the market followed by Europe.The large share of this geographical segment is attributed to the increasing investments for the development of structure-based drug designs, growing research in the field of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and the focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.Based on application, the in vitro diagnostics segment is expected to register the highest CAGR during the forecast periodBased on application, the neuroscience antibodies and assays market is segmented into research, drug discovery and development, and in vitro diagnostics.The in vitro diagnostics applications segment is expected to register the highest CAGR during the forecast period.The high growth of this segment is attributed to the increasing incidence and prevalence of neurological diseases across the globe, especially in developing countries.The immunoassays/immunochemistry segment is expected to dominate the neuroscience antibodies and assays market in 2018Based on technology, the neuroscience antibodies market is segmented into immunoassays/immunochemistry, molecular diagnostics, clinical chemistry, and other technologies.The large share of this segment is attributed to the development of novel antibodies and assays for immunoassay techniques, technological developments in immunoassays, and rising government initiatives in the genomics and proteomics research sector.Based on product, the neuroscience antibodies market is segmented into consumables and instruments.
According to research report the global dental devices market is projected to reach USD 7.52 billion by 2021 from an estimated USD 5.93 billion in 2016, at a CAGR of 4.9%Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784Factors such as the rapidly growing elderly population, increasing incidence of dental caries and other periodontal diseases, and growing demand for cosmetic dentistry are driving the growth of the dental equipment market.During the forecast period, Europe holds the largest share of this market.The major factors driving the growth of the European dental equipments market include the rising geriatric population, growing governmental expenditure on oral healthcare across Europe, and the high reimbursement rate in Germany, Sweden, and the Netherlands.Based on product, the dental devices market is split into general dental equipment, dental diagnostic equipment, and dental therapeutic equipment.Improvements and enhancements in product designs have facilitated the provision of better dental care services to patients.The availability of portable and integrated solutions enables differentiation in dental practices.The growing demand for the innovative dental products is expected to propel the growth of this market segment.Danaher Corporation (U.S.), Planmeca OY (Finland), Dentsply Sirona (U.S.), and Carestream Health, Inc. (U.S.) held a major share of the dental equipment market.
According to the new market research report Healthcare IT Integration Market is projected to reach USD 6.0 billion by 2025 from USD 3.5 billion in 2020, at a CAGR of 11.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=228536178The increasing need for integration primarily drives the market for healthcare IT integration solutions as a result of the rising healthcare costs and the growing volume of data generated in healthcare systems.The need to improve patient safety and favorable government and private support for HCIT will also contribute to market growth in the coming years.However, the high cost of HCIT integration is limiting the overall adoption of these solutions.The prominent players in this Healthcare IT Integration Market are Infor (US), InterSystems Corporation (US), Cerner Corporation (US), Orion Health (New Zealand), NextGen Healthcare Inc. (US), iNTERFACEWARE, Inc. (Canada), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US), GE Healthcare (US), IBM (US), Oracle Corporation (US), Capsule Technologies, Inc. (US), Koninklijke Philips (Netherlands), AVI-SPL, Inc. (US), Corepoint Health (US), and MEDITECH (US).North America to hold the largest regional Healthcare Integration IT Market share in 2019.North America is expected to account for the largest share of the Healthcare Integration Market in 2019, followed by Europe.The large share of North America can be attributed to the high adoption of healthcare IT technologies, initiatives undertaken by the US Federal government towards improving patient care and reducing healthcare costs, and the growing need for the optimization of healthcare infrastructure.In addition, factor such as the widespread adoption of clinical device connectivity and interoperability solutions to curtail the rising healthcare costs, rising number of coronavirus (COVID-19) patients in the US, and stringent regulations and guidelines laid down by the various government and non-government authorities such as the Health Insurance Portability and Accountability Act (HIPPA), the Federal Communications Commission (FCC), and the Centers for Medicare and Medicaid Services (CMS) are further driving the growth of the Healthcare IT Integration Solutions Market in North America.The services segment is expected to for the largest share of the Healthcare IT Integration Market in 2019.Based on product & service, the market is categorized mainly into products and services.In 2019, the services segment was expected to account for the largest share of the Healthcare IT Integration Solutions Market.
According to the new market research report restorative dentistry market is expected to reach USD 21.27 Billion by 2022 from an estimated USD 15.60 Billion in 2017, at a CAGR of 6.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210042423 Factors such as rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism in emerging markets, rising incidence of dental caries and other periodontal diseases, increasing outsourcing of customization and fabrication of restorative and prosthetic products to restorative dentistry, and increasing demand for restorative dentistry are driving the growth of the global restorative dentistry market.Europe dominated the restorative dentistry market in 2016Europe accounted for the largest share of the restorative dentistry devices market in 2016, followed by North America.The large share of this region is attributed to the increasing prevalence of dental diseases; growth in the aging population; increasing demand for advanced cosmetic dental procedures; growing dental tourism in some European countries; increasing number of dental clinics, hospitals, and laboratories; and growing adoption of technologically advanced procedures, such as CAD/CAM systems by dental professionals.Hospitals & clinics to witness the highest growth during the forecast periodOn the basis of end user, the dental restoration market is segmented into hospitals & clinics, dental schools & research institutes, and dental laboratories.The hospitals & clinics segment accounted for the major share of the global dental restoration market and is expected to register the highest CAGR during the forecast period.The large share of this end-user segment is attributed to the increasing number of dental clinics and hospitals especially in emerging markets, rapid adoption of advanced technologies in these settings, and growth in the target patient population.The restorative materials segment is expected to grow at the fastest rate during the forecast periodBased on product, the restorative dentistry market is segmented into restorative materials, implants, prosthetics, and restorative equipment.The dental restorative materials segment accounted for the major share of the global dental restoration market and is expected to register the highest CAGR during the forecast period.The large share and high growth of this segment can primarily be attributed to the growing number of tooth repair procedures, high cost of restorative materials, increasing adoption of customized prosthetics, and increasing demand for cosmetic dentistry.The major players in the restorative dentistry market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), Institut Straumann (Switzerland), 3M Company (US), Zimmer Biomet Holdings, Inc. (US), Ultradent Products, Inc. (US), GC Corporation (Japan), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), Ivoclar Vivadent AG (Liechtenstein), COLTENE Holding (Switzerland), and VOCO (Germany).Request Free Report Sample: http://www.marketsandmarkets.com/requestsample.asp?id=210042423
According to research report the Thrombectomy Devices Market is expected to reach USD 1.45 Billion by 2022 growing at a CAGR of 6.7%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222966801This large thrombectomy devices market share is mainly attributed to factors such as increasing prevalence of cardiovascular diseases across major markets, higher prevalence of thrombotic diseases among geriatric individuals, procedural benefits offered by mechanical thrombectomy in cardiac surgeries and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries.Asia-Pacific thrombectomy devices market is expected to grow at the highest CAGR during 2017-2022.This is primarily due to the presence of large target patient population, increasing healthcare expenditure, increase in localized manufacturing & strengthening of distribution networks, and rising awareness among surgeons related to the benefits offered by thrombectomy devices.On the basis of application, the global thrombectomy procedure market is segmented into neurovascular, cardiovascular, and peripheral vascular applications.The cardiovascular applications segment accounted for the largest share of the market in 2016.The large share of this segment is attributed to the increasing prevalence of cardiovascular diseases, procedural benefits offered by mechanical thrombectomy in cardiac surgeries, higher prevalence of thrombotic diseases among geriatric individuals, and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries.On the basis of type, the global thrombectomy devices market is segmented into aspiration, mechanical/fragmentation, rheolytic/hydrodynamic, and ultrasonic thrombectomy devices.The mechanical/fragmentation thrombectomy devices segment accounted for the largest share of the market in 2016.This large share is attributed to the ongoing commercialization of mechanical thrombectomy products, favorable reimbursement scenario, established therapeutic efficacy, growing market demand for stent retrievers among medical professionals, and rising end-user preference for minimally invasive thrombectomy procedures.On the basis of end users, the global thrombectomy procedure market is segmented into hospitals & surgical centers, ambulatory surgical centers, research laboratories & academic institutes, and other end users.
According to the new market research report Sternal Closure Devices Market is estimated to be valued at USD 2.02 billion in 2018 and is projected to reach USD 2.61 billion by 2023, at a CAGR of 5.2%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152164684Factors such as technological advancements in sternotomy techniques, increasing target patient population coupled with the subsequent increase in the number of surgical procedures, and growing availability of medical reimbursements across major markets are expected to drive the demand for sternal closure systems during the study period.In 2017, North America accounted for the largest share of the sternal closure systems marketGeographically, the sternal closure devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.North America accounted for the largest share of the market in 2017.The presence of a large patient population accompanied by a well established medical reimbursement policy is expected to drive the growth of this region.Based on product, the closure devices segment is expected to register the highest growth rate during the forecast periodBased on product, the sternal closure systems market is divided into closure devices and bone cement.Among these segments, closure devices are expected to grow at the highest CAGR during the forecast period.Factors such as increasing number of complex cardiovascular surgeries and growing availability of medical reimbursements across developed markets are expected to drive the growth of the closure devices segment in the next five years.Based on procedure, the median sternotomy segment is estimated to be the largest segment of the market in 2018The sternal closure systems market is segmented by procedure into median sternotomy, hemisternotomy, and bilateral thoracosternotomy.The median sternotomy segment is expected to account for the largest share of the sternal closure devices market in 2018, owing to rising number of critical patients suffering from cardiovascular diseases.Based on material, the titanium material segment is expected to register the fastest growth rate in the forecast periodBased on material, the sternal closure devices market for closure devices is classified into stainless steel, PEEK, and titanium products.
According to research report the global Genome Engineering Market is projected to reach USD 6.28 billion by 2022 from USD 3.19 billion in 2017, at a CAGR of 14.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000The key factors propelling the growth of this genome editing market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.In 2017, North America is projected to have the highest growth rate during the forecast period.Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.The global genome editing market, by application, is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics).The cell line engineering segment is estimated to register the highest growth rate during the forecast period.Factors such as increasing funding from governments and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are driving the growth of the cell line engineering segment.Based on end user, the global genome engineering market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations.The biotechnology & pharmaceutical companies’ segment is estimated to register the highest growth rate during the forecast period.The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.Based on technology, the genome engineering market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In).
According to research report wearable healthcare devices market size is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 This market is largely driven by the increasing awareness of fitness and healthy lifestyles, development of technologically advanced products, growing geriatric population and subsequent increase in the incidence of chronic diseases, cost-containment in healthcare delivery, robust penetration of 3G and 4G networks for uninterrupted healthcare services, increasing penetration of smartphones and the growing number of smart-phone based healthcare apps and growing preference for wireless connectivity among healthcare providers are driving the growth of the global wearable healthcare devices industry.Growing adoption of mobile platforms, increasing adoption of AI and 5G, and the growing awareness & preference for home healthcare are opening opportunities for the growth of the market.In 2019, North America accounted for the largest share of 38.0% of the global wearable medical devices market.In 2019, the general health and fitness segment accounted for the largest share of the market, primarily due to the increasing focus on physical fitness among people to improve their quality of life, coupled with the growing trend of tracking health progress on a continuous basis.In 2019, the diagnostic & monitoring devices segment accounted for a larger share of 64.3% of the wearable medical devices market.
According to the new market research Liquid Biopsy Market is expected to reach $2,047.9 Million by 2022 from an estimated $715.7 Million in 2017, at a CAGR of 23.4%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350The key factors driving the growth of this market include increasing prevalence of cancer, initiatives undertaken by government and global health organizations, increasing preference for non-invasive procedures, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy RNorth America is expected to dominate the market in 2017North America is expected to account for the largest share of the liquid biopsy market in 2017, followed by Europe.A number of factors such as the easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS) among healthcare professionals, rising prevalence of cancer in the US and Canada, technological advancements in liquid biopsy products, and growing public and private funding to support research activities in the field of liquid biopsy are aiding market growth in the region.By circulating biomarkers, circulating tumor cells is expected to account for the largest market share in 2017Based on circulating biomarkers the market is categorized into circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.In 2017, the circulating tumor cells segment is expected to account for the largest share of the liquid biopsy devices market.The ability for early assessment of patient prognosis and also providing valuable information to make a clinical decision is driving the growth of the CTC segment in the liquid biopsy market.By clinical application, the therapy selection segment is expected to account fors the largest market share in 2017Based on clinical application, the liquid biopsy market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring.The therapy selection segment is expected to account for the largest share of the liquid biopsy devices market in 2017.This is due to the ability of therapy selection to detect advanced-stage cancers (stage III and IV), followed by increasing studies on liquid biopsy and advancements made in this field to also aid in detection of early-stage cancers.By product, the assay kits segment is expected to account for the largest share of the market in 2017On the basis of product, the liquid biopsy market is broadly segmented into assays kits, instruments, and services.
According to research report Healthcare Middleware Market is expected to reach USD 3.07 Billion by 2023 from USD 1.90 Billion in 2018, at a CAGR of 10.0%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258951459 Increasing utilization of smart devices, availability of big data in healthcare, increasing need for data interoperability, and growing investments to overcome healthcare interoperability issues are the key drivers of the global market for middleware in healthcare.In 2018, North America to dominate the healthcare middleware market In 2018, North America is expected to command the largest share of the market, followed by Europe, Asia, and the Rest of the World.The large share of North America is attributed to factors such as the implementation of federal health mandates to encourage the adoption of HCIT solutions, rising pressure to curb healthcare costs, increasing investment to improve data interoperability, and the growing adoption of smart devices.Based on application, the clinical application segment is expected to register the highest CAGR during the forecast period Based on application, the healthcare middleware market is segmented into clinical, financial, and operational and administrative applications.The clinical applications segment is expected to account for the largest share of the healthcare middleware market and is projected to register the highest CAGR during the forecast period.
According to research report the global Genome Engineering Market is projected to reach USD 6.28 billion by 2022 from USD 3.19 billion in 2017, at a CAGR of 14.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000The key factors propelling the growth of this genome editing market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.In 2017, North America is projected to have the highest growth rate during the forecast period.Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.The global genome editing market, by application, is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics).The cell line engineering segment is estimated to register the highest growth rate during the forecast period.Factors such as increasing funding from governments and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are driving the growth of the cell line engineering segment.Based on end user, the global genome engineering market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations.The biotechnology & pharmaceutical companies’ segment is estimated to register the highest growth rate during the forecast period.The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.Based on technology, the genome engineering market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In).
According to research report wearable healthcare devices market size is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 This market is largely driven by the increasing awareness of fitness and healthy lifestyles, development of technologically advanced products, growing geriatric population and subsequent increase in the incidence of chronic diseases, cost-containment in healthcare delivery, robust penetration of 3G and 4G networks for uninterrupted healthcare services, increasing penetration of smartphones and the growing number of smart-phone based healthcare apps and growing preference for wireless connectivity among healthcare providers are driving the growth of the global wearable healthcare devices industry.Growing adoption of mobile platforms, increasing adoption of AI and 5G, and the growing awareness & preference for home healthcare are opening opportunities for the growth of the market.In 2019, North America accounted for the largest share of 38.0% of the global wearable medical devices market.In 2019, the general health and fitness segment accounted for the largest share of the market, primarily due to the increasing focus on physical fitness among people to improve their quality of life, coupled with the growing trend of tracking health progress on a continuous basis.In 2019, the diagnostic & monitoring devices segment accounted for a larger share of 64.3% of the wearable medical devices market.
According to research report the global In Vitro Diagnostics Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582Key players are focusing on increasing their presence in this growing market through both organic as well as inorganic growth strategies, such as product launches, agreements, partnerships, collaborations, and expansions.Due to the intense competition in the In Vitro Diagnostics Quality Control Market, various market players are increasingly focusing on expanding their geographic presence in high-growth emerging markets.Bio-Rad Laboratories Inc. (US) was the leading player in the In Vitro Diagnostics Quality Control Market and accounted for the largest share in 2018.The company is a leading provider of clinical diagnostic systems, analytical devices, and instruments.The company has a robust portfolio of quality control products, data management solutions and quality assurance services for hospital laboratories, reference laboratories, transfusion laboratories, and physician office laboratories.For instance, in May 2019, the company launched InteliQ and Load-and-Go Tubes for quality controls to streamline the laboratory workflow.With this new launch the company enabled to strengthen its chemistry and immunoassay quality controls offerings.Randox Laboratories Ltd. (UK) held the second-largest share of the global IVD quality control market.
More

Top